#176 | How Clinicians NEED to Prioritise What Actually Drives Revenue In Their Medical Device Go-To-Market Strategy
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
#176 | How Clinicians NEED to Prioritise What Actually Drives Revenue In Their Medical Device Go-To-Market Strategy
-
ナレーター：
-
著者：
概要
When your MedTech launch has several weak points, how do you know which one to fix first before you waste 90 days improving the wrong thing?
MedTech founders rarely fail because the device is poor. More often, they stall because they improve the wrong part of their launch first. When product, proof, pathway, and people all have room for improvement, deciding where to focus becomes critical. In this episode, Hakeem breaks down a practical decision rule that helps you identify the one move most likely to unlock real contracts and meaningful revenue.
By listening, you’ll:
- Learn why the lowest-scoring weakness is not always the first problem you should solve
- Understand how commercial conversations reveal whether proof, pathway, or people is the real revenue constraint
- Use a simple 90-day decision filter to prioritize the move most likely to accelerate traction this quarter
Press play now to identify the one change that can move your MedTech launch closer to real contracts and meaningful revenue
Book a 30min Healthcare Export Accelerator discovery call
Message me via DM on Linkedin
This podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.